Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Amortizatization of Intangibles (2024 - 2025)

Autolus Therapeutics (AUTL) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles changed N/A year-over-year to $2.2 million, compared with a TTM value of $2.9 million through Sep 2025, changed N/A, and an annual FY2024 reading of $162000.0, changed N/A over the prior year.
  • Amortizatization of Intangibles was $2.2 million for Q3 2025 at Autolus Therapeutics, up from $300000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.2 million in Q3 2025 and bottomed at $162000.0 in Q4 2024.